Another gene strongly implicated in AD is PPARγ, whose AD-related activities include possible inhibition of β-site amyloid cleaving enzyme 1 (BACE1)86 and SNP-based interaction with apolipoprotein E to alter AD risk87, among many other possible connections. Here, BACE1 is linked to Alzheimer disease.